Literature DB >> 3697070

cDNA and amino acid sequences of two members of the human P450IIC gene subfamily.

S Kimura1, J Pastewka, H V Gelboin, F J Gonzalez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3697070      PMCID： PMC306558          DOI： 10.1093/nar/15.23.10053

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  6 in total

1.  The P450 gene superfamily: recommended nomenclature.

Authors:  D W Nebert; M Adesnik; M J Coon; R W Estabrook; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson; B Kemper; W Levin
Journal:  DNA       Date:  1987-02

2.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

3.  Random subcloning of sonicated DNA: application to shotgun DNA sequence analysis.

Authors:  P L Deininger
Journal:  Anal Biochem       Date:  1983-02-15       Impact factor: 3.365

4.  Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase.

Authors:  D R Umbenhauer; M V Martin; R S Lloyd; F P Guengerich
Journal:  Biochemistry       Date:  1987-02-24       Impact factor: 3.162

5.  Sequence of two related P-450 mRNAs transcriptionally increased during rat development. An R.dre.1 sequence occupies the complete 3' untranslated region of a liver mRNA.

Authors:  F J Gonzalez; S Kimura; B J Song; J Pastewka; H V Gelboin; J P Hardwick
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205
  6 in total
  7 in total

Review 1.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 2.  Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.

Authors:  J A Goldstein
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

3.  Studies of binding modes of (S)-mephenytoin to wild types and mutants of cytochrome P450 2C19 and 2C9 using homology modeling and computational docking.

Authors:  Akifumi Oda; Noriyuki Yamaotsu; Shuichi Hirono
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 4.  P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease.

Authors:  M Murray
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

5.  Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.

Authors:  M E Veronese; C J Doecke; P I Mackenzie; M E McManus; J O Miners; D L Rees; R Gasser; U A Meyer; D J Birkett
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

Review 6.  Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.

Authors:  J O Miners; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

Review 7.  Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.

Authors:  Ann K Daly; Allan E Rettie; Douglas M Fowler; John O Miners
Journal:  J Pers Med       Date:  2017-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.